...
首页> 外文期刊>Oncology reports >Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians
【24h】

Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians

机译:全球粪便microRNA分析技术在亚洲人大肠癌筛查生物标志物的鉴定中

获取原文
获取原文并翻译 | 示例
           

摘要

Fecal microRNAs (miRNAs) are increasingly explored as non-invasive markers of colorectal cancer (CRC). However, its holistic profile in Asian CRC patients remains elusive. In the present study, the global human fecal miRNAs in Asian Chinese CRC patients was assayed to elucidate novel diagnostic fecal markers. Additionally, the influence of blood in stool on fecal miRNA levels was investigated for the first time. Microarray analysis was applied to profile the fecal miRNAs extracted from CRC patients and healthy subjects. Concurrently, surgically resected tumor and matched normal mucosae were analyzed. Potential fecal miRNA markers were further confirmed using real-time PCR in 17 CRC patients and 28 healthy subjects. Global miRNA profiling uncovered 17 fecal markers (P<0.05) differentially regulated in CRC. Fecal miR-223 and miR-451 represented robust markers in distinguishing CRC patients from healthy subjects, as evident from areas under the receiver operator characteristic curves of 0.939 and 0.971, respectively. Blood in stool affected fecal miR-451, miR-223 and miR-135b levels to a varying extent and substantially impacted the interpretation of the clinical data. Notably, a discrete set of aberrant miRNAs occurred within the tumor, indicating the presence of contributors beyond the exfoliation of tumor cells to the fecal miRNA profile. In summary, the utility of a global miRNA screening approach was successfully demonstrated in elucidating diagnostic markers of CRC. In particular, fecal miR-223 and miR-451 hold promise in detecting CRC.
机译:粪便microRNA(miRNA)越来越多地被用作结直肠癌(CRC)的非侵入性标记。但是,其在亚洲CRC患者中的整体情况仍然难以捉摸。在本研究中,对亚洲中国CRC患者的全球人类粪便miRNA进行了分析,以阐明新型诊断性粪便标志物。此外,首次研究了粪便中的血液对粪便miRNA水平的影响。应用微阵列分析来分析从CRC患者和健康受试者中提取的粪便miRNA。同时,分析了手术切除的肿瘤和匹配的正常粘膜。使用实时PCR在17名CRC患者和28名健康受试者中进一步证实了潜在的粪便miRNA标记。全局miRNA分析发现CRC中有17种粪便标志物(P <0.05)受到差异调节。粪便miR-223和miR-451代表了将CRC患者与健康受试者区分开的强大标记,从接收者操作员特征曲线分别为0.939和0.971的区域可以明显看出。粪便中的血液会在不同程度上影响粪便中miR-451,miR-223和miR-135b的水平,并严重影响临床数据的解释。值得注意的是,一组离散的异常miRNA发生在肿瘤内,这表明除了肿瘤细胞剥落至粪便miRNA谱外,还存在其他贡献者。总之,成功地证明了全球miRNA筛选方法在阐明CRC诊断标记中的实用性。尤其是,粪便miR-223和miR-451在检测CRC中有希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号